Equity (Details) - Schedule of pre-funded warrant activity - Warrant [Member] shares in Thousands |
12 Months Ended |
---|---|
Dec. 31, 2020
USD ($)
$ / shares
shares
| |
Equity (Details) - Schedule of pre-funded warrant activity [Line Items] | |
Number of Warrants, Outstanding, Beginning | shares | |
Weighted Average Exercise Price, Beginning | $ / shares | |
Aggregate Intrinsic Value, Beginning | $ | |
Number of Warrants, Granted | shares | 3,459 |
Weighted Average Exercise Price, Granted | $ / shares | $ 0.003 |
Number of Warrants, Exercised | shares | (3,459) |
Weighted Average Exercise Price, Exercised | $ / shares | $ 0.003 |
Number of Warrants, Outstanding, Ending | shares | |
Weighted Average Exercise Price, Ending | $ / shares | |
Aggregate Intrinsic Value, Ending | $ |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. No definition available.
|
X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. No definition available.
|
X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. No definition available.
|
X | ||||||||||
- Definition Number of non-vested options outstanding. No definition available.
|
X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. No definition available.
|
X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|